Ruchika Goel1, Daniel J Johnson2, Andrew V Scott2, Aaron A R Tobian3, Paul M Ness3, Enika Nagababu2, Steven M Frank2. 1. Departments of Pathology and Pediatric Hematology/Oncology, New York Presbyterian Hospital, Weill Cornell Medical College, and The New York Blood Center, New York, New York. 2. Department of Anesthesiology/Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland. 3. Department of Pathology (Transfusion Medicine), The Johns Hopkins Medical Institutions, Baltimore, Maryland.
Abstract
BACKGROUND: Clinical trials have shown that longer red blood cell (RBC) storage duration does not worsen outcomes; however, these studies included few RBCs near the end of the 42-day storage limit. We tested the hypothesis that these "oldest" RBCs are associated with adverse outcomes. STUDY DESIGN AND METHODS: In a retrospective study, 28,247 transfused patients given 129,483 RBC units were assessed. Morbidity, mortality, and length of stay (LOS) were compared in patients transfused exclusively with RBCs stored not more than 21 days versus patients transfused exclusively with RBCs stored 28 days or more and patients transfused exclusively with RBCs stored 35 days or more. RESULTS: After risk adjustment, ≥35-day RBCs were associated with increased morbidity (adjusted odds ratio [adjOR], 1.19; 95% confidence interval [CI], 1.07-1.32; p = 0.002), but ≥28-day RBCs were not (adjOR, 1.06; 95% CI, 0.97-1.15; p = 0.2). Neither ≥35-day nor ≥28-day RBCs were associated with increased mortality. In critically ill patients, ≥35-day RBCs were associated with increased morbidity (adjOR, 1.25; 95% CI, 1.08-1.44; p = 0.002) and mortality (adjOR, 1.38; 95% CI, 1.08-1.74; p = 0.009), but ≥28-day RBCs were associated with neither. In older patients, ≥35-day RBCs were associated with increased morbidity (adjOR, 1.22; 95% CI, 1.04-1.42; p = 0.01), but not mortality (adjOR, 1.28; 95% CI, 0.96-1.71; p = 0.1), and ≥28-day RBCs were associated with neither. LOS was increased for both ≥28- and ≥35-day RBCs for all patients and the critically ill and older subgroups. CONCLUSIONS: RBCs transfused in the last 7 days of their 42-day storage limit may be associated with adverse clinical outcomes in high-risk patients.
BACKGROUND: Clinical trials have shown that longer red blood cell (RBC) storage duration does not worsen outcomes; however, these studies included few RBCs near the end of the 42-day storage limit. We tested the hypothesis that these "oldest" RBCs are associated with adverse outcomes. STUDY DESIGN AND METHODS: In a retrospective study, 28,247 transfused patients given 129,483 RBC units were assessed. Morbidity, mortality, and length of stay (LOS) were compared in patients transfused exclusively with RBCs stored not more than 21 days versus patients transfused exclusively with RBCs stored 28 days or more and patients transfused exclusively with RBCs stored 35 days or more. RESULTS: After risk adjustment, ≥35-day RBCs were associated with increased morbidity (adjusted odds ratio [adjOR], 1.19; 95% confidence interval [CI], 1.07-1.32; p = 0.002), but ≥28-day RBCs were not (adjOR, 1.06; 95% CI, 0.97-1.15; p = 0.2). Neither ≥35-day nor ≥28-day RBCs were associated with increased mortality. In critically illpatients, ≥35-day RBCs were associated with increased morbidity (adjOR, 1.25; 95% CI, 1.08-1.44; p = 0.002) and mortality (adjOR, 1.38; 95% CI, 1.08-1.74; p = 0.009), but ≥28-day RBCs were associated with neither. In older patients, ≥35-day RBCs were associated with increased morbidity (adjOR, 1.22; 95% CI, 1.04-1.42; p = 0.01), but not mortality (adjOR, 1.28; 95% CI, 0.96-1.71; p = 0.1), and ≥28-day RBCs were associated with neither. LOS was increased for both ≥28- and ≥35-day RBCs for all patients and the critically ill and older subgroups. CONCLUSIONS: RBCs transfused in the last 7 days of their 42-day storage limit may be associated with adverse clinical outcomes in high-risk patients.
Authors: Angelo D'Alessandro; Rachel Culp-Hill; Julie A Reisz; Mikayla Anderson; Xiaoyun Fu; Travis Nemkov; Sarah Gehrke; Connie Zheng; Tamir Kanias; Yuelong Guo; Grier Page; Mark T Gladwin; Steve Kleinman; Marion Lanteri; Mars Stone; Michael Busch; James C Zimring Journal: Transfusion Date: 2018-10-24 Impact factor: 3.157
Authors: Francesca Rapido; Gary M Brittenham; Sheila Bandyopadhyay; Francesca La Carpia; Camilla L'Acqua; Donald J McMahon; Abdelhadi Rebbaa; Boguslaw S Wojczyk; Jane Netterwald; Hangli Wang; Joseph Schwartz; Andrew Eisenberger; Mark Soffing; Randy Yeh; Chaitanya Divgi; Yelena Z Ginzburg; Beth H Shaz; Sujit Sheth; Richard O Francis; Steven L Spitalnik; Eldad A Hod Journal: J Clin Invest Date: 2016-12-12 Impact factor: 14.808
Authors: Sofie L Rygård; Andreas B Jonsson; Martin B Madsen; Anders Perner; Lars B Holst; Pär I Johansson; Jørn Wetterslev Journal: Intensive Care Med Date: 2018-01-25 Impact factor: 17.440